Maxalt RPD

Medicinal product

(Invented) name

Maxalt RPD

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-02-20

Date of renewal

Documents

2393_Maxalt RPD 10mg_ger_liof_PZ_2025-02-20.docx

2393_Maxalt RPD 10mg_ger_liof_PL_2025-02-20.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra:	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116709	102810	1102810	lizdinė plokštelė	N3		Receptinis	LT/L/25/2393/001	Tiekiama	2025-07-31	-	No	-	-	Download
116710	102811	1102811	lizdinė plokštelė	N6		Receptinis	LT/L/25/2393/002	Tiekiama	2025-10-07	-	No	-	-

Stadijos

Data	Stadija
2025-02-20	Registruotas